Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | HMGCR | P04035 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.43 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4424259 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL3119123 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL5180314 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL3122448 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL7610120 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL3122405 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL5181358 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL4425881 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL769486 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS | |
| SCHEMBL7608679 | 1.00 | GPR84 (0.50) | GPR84FFAR1MAPTFFAR4FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8313755-B2 | Long-chain fatty acid having 12 to 24 carbon atoms, a nonionic surface active agent; cosmetics, bath agents, hair-care products, external preparations for the skin | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| EP-1153595-B1 | Clear aqueous ceramide composition | TAKASAGO PERFUMERY CO LTD (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20020010215-A1 | Clear aqueous ceramide composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1153595-A2 | Clear aqueous ceramide composition | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010215-A1 | Clear aqueous ceramide composition | CERS2, CERT1, SGMS1 | GPR84 817/4885FFAR1 50/4885MAPT 2523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.